Kcs Wealth Advisory Novartis Ag Transaction History

Kcs Wealth Advisory

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 15, 2020	SELL	$84.35 - $95.37 $170,302 - $192,552	-2,019 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$85.54 - $94.26 $44,138 - $48,638	-516 Reduced 20.36%	2,019 $175,000
Q2 2019 Jul 29, 2019	SELL	$75.4 - $92.8 $9,425 - $11,600	-125 Reduced 4.7%	2,535 $231,000
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $14,310 - $16,368	-190 Reduced 6.67%	2,660 $256,000
Q4 2018 Jan 17, 2019	SELL	$73.66 - $82.02 $5,966 - $6,643	-81 Reduced 2.76%	2,850 $245,000
Q3 2018 Nov 06, 2018	SELL	$66.94 - $77.43 $112,392 - $130,004	-1,679 Reduced 36.42%	2,931 $253,000
Q2 2018 Aug 07, 2018	SELL	$64.91 - $73.36 $26,223 - $29,637	-404 Reduced 8.06%	4,610 $348,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $28,789 - $34,417	-409 Reduced 7.54%	5,014 $405,000
Q4 2017 Jan 12, 2018	BUY	$72.33 - $77.64 $392,245 - $421,041	5,423	5,423 $455,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Kcs Wealth Advisory, based on Form 13F filings with the SEC.

Stay updated on Kcs Wealth Advisory with notifications on news.